Peptides, Explained · Part 3 of 5
Growth hormone boosters
Tesamorelin, MK-677 and the peptide-clinic menu — real biology, and a trade-off the marketing skips.
Our full video overview of the peptide landscape, including the growth hormone trade-off discussed in this article.
This is the group behind the dramatic transformations — the twelve-week changes that look impossible. The biology is genuinely real. The trade-off is genuinely poorly understood, and the marketing tends to mention the first part and skip the second.
Mixed Real biology and some human data, but no approvals for what people actually use these for, and a longevity question that runs in the wrong direction.
First, how the system works
These compounds do not give you growth hormone. They poke the gland that makes it, so your own body produces more. Understanding the chain makes everything else in this article clearer.
Step one: your hypothalamus, deep in the brain, releases GHRH — growth hormone releasing hormone.
Step two: GHRH travels a very short distance to the pituitary gland just below it, which responds by releasing growth hormone into the bloodstream — in pulses rather than a steady stream, mostly at night during deep sleep.
Step three: growth hormone reaches the liver, which converts that signal into IGF-1. IGF-1 is what actually travels to your muscles, bones and skin and tells them to grow and repair. It is the number people measure, because it is the steady downstream readout of a hormone that arrives in unpredictable bursts.
The compounds below split into two groups. Some copy step one, poking the pituitary through the GHRH door. Others come in through a second, separate door on the same gland — the ghrelin receptor. Because those two doors use different signalling pathways inside the cell, opening both at once produces a bigger release than either alone. That is the entire logic behind why clinics pair them.
What you get, and what it costs
In the short term this delivers what people want: a leaner body, faster recovery, better skin and sleep, a general sense of feeling younger. Those effects are real and they are why the category sells.
The cost is the part that gets skipped. Your body handles blood sugar worse. You retain fluid. Joints and wrists ache, sometimes to the point of carpal-tunnel symptoms. And a growth signal grows everything it reaches — including the prostate, and in theory a tumor you do not know you have.
Then there is the longevity question. Across species, less growth signaling tends to track with living longer: small dog breeds outlive giant ones, and the gene that determines dog body size is the IGF-1 gene. That correlation is real, though giant-breed dogs also die early for reasons beyond growth signaling, so treat it as an illustration rather than proof.
More youthful now, possibly less time overall. This is the clearest example in the whole series of a compound doing exactly what it promises in the short term while the long-term direction of travel points the other way.
Tesamorelin
What it is: a copy of the step-one signal. Sold as Egrifta SV, and it is genuinely FDA-approved — but only for reducing excess belly fat in people with HIV-related fat redistribution. The label explicitly states it is not for weight loss.
Natural GHRH is destroyed within minutes by the same enzyme that destroys GLP-1, so tesamorelin carries a chemical group on one end that blocks the enzyme from getting a grip.
Because it acts at the top of the chain rather than replacing growth hormone itself, your pituitary still releases it in natural pulses and your body's normal shut-off feedback still applies. That is the argument for why these are considered gentler than injecting growth hormone directly — the ceiling is still partly set by your own physiology.
As for why belly fat specifically: growth hormone switches on an enzyme inside fat cells that releases stored fat, and visceral fat — the deep fat packed around your organs — carries an unusually high density of growth hormone receptors. So it responds earlier and harder than fat elsewhere.
The catch: raises IGF-1, worsens blood sugar and increases diabetes risk, causes swelling and joint pain. Off limits with an active cancer, in pregnancy, or with pituitary problems. Combined with ipamorelin, people push IGF-1 into the high 300s — at or above the top of the normal adult range, and held there continuously rather than in natural pulses. That sustained elevation, rather than the number itself, is where the risk concentrates.
MK-677 (ibutamoren)
What it is: a pill, not a peptide, and not approved for anything. It mimics ghrelin — your hunger hormone — at the second door.
What the evidence shows: this is the most instructive result in the article. A two-year trial in adults aged 60 to 81 found it added about a kilogram of lean mass — and produced no improvement in strength or physical function. A separate 563-patient Alzheimer's trial found nothing at all. Adding mass on a scan is not the same as being healthier or more capable.
When your stomach is empty it releases ghrelin. That hormone binds a receptor sitting in two important places: on the growth-hormone-producing cells of the pituitary, and on the hunger neurons of the hypothalamus. MK-677 mimics ghrelin at that receptor, which is also why it can be a pill rather than an injection.
But the receptor does not distinguish between the effects you wanted and the ones you didn't. The same signal that releases growth hormone also drives appetite, and nudges prolactin and cortisol. There is no way to activate it for muscle and skip the hunger, because it is one receptor doing one job in several places at once.
The catch: very strong appetite increase, fluid retention (44% of people in the two-year trial), aching joints and muscles (33%), worse fasting blood sugar and insulin resistance.
The clinic menu
Sermorelin, ipamorelin, CJC-1295, the GHRPs, macimorelin — these are the names on a wellness clinic's price list. They sort neatly onto the two doors. Sermorelin and CJC-1295 are GHRH copies; ipamorelin and the GHRPs are ghrelin-receptor agonists, injectable and more selective than MK-677.
Two things worth knowing. Macimorelin is FDA-approved — but only as a diagnostic test. You give it, draw blood four times over 90 minutes, and see whether the pituitary responds. It is approved as a test of the system, not a treatment for it, and a clinic implying otherwise is stretching the truth. Sermorelin was genuinely approved in the 1990s, but the manufacturer discontinued that product in 2008, so everything sold today comes from a compounding pharmacy and is not itself an FDA-approved product.
Andrew Huberman described taking sermorelin: his deep sleep improved, but his REM sleep was wiped out and his PSA — the prostate marker — spiked. It came back down after he stopped.
That is the prostate-growth concern showing up in a healthy, careful, and unusually well-monitored person who was actively measuring. Most people using these are measuring nothing.
The honest summary
If someone is going to use these, the non-negotiable is monitoring: IGF-1, blood sugar and A1c, and prostate markers, tracked over time with a physician, and treated as a cyclical experiment rather than a drug you take forever. That is the version with a defensible risk profile.
Almost nobody buying these online is doing any of that. And it is worth saying plainly that a large fraction of what people chase here — better recovery, better body composition, better sleep — is available from training, protein and sleep itself, with no prostate question attached.
Educational information, not medical advice. Nothing here is a recommendation to use or avoid any compound, and no doses are given. Most compounds discussed in this series are not FDA-approved and have no established human dose. Anyone considering them should work with a qualified physician and a regulated pharmacy. Prototype Training Systems does not sell, supply, prescribe or administer any of these.
- What Are Peptides and Why All The Buzz?
- Ozempic, Zepbound and the Weight-Loss Shots Explained
- Growth Hormone Peptides: MK-677, Tesamorelin and Ipamorelin — you are here
- BPC-157 and TB-500 — coming soon
- The rest of the landscape — coming soon
The foundation is the part that works
Every honest read of this evidence lands in the same place: sleep, protein, consistent training and real bloodwork is where nearly all of the benefit lives. That is what we coach. Start with a free No Sweat Intro — a conversation about where you are and where you want to go.
Book a Free No Sweat IntroThis article was researched and drafted with the help of AI writing tools, then fact-checked against primary sources — published clinical trials, FDA labels and regulatory records. Where our source material contained errors, they were corrected against those sources rather than repeated.
